We’re excited about the approval of mRESVIA® (Respiratory Syncytial Virus Vaccine) in the United States. With the approval of mRESVIA, Moderna is the first and only company in the world with two FDA-approved #mRNA #vaccine products. It is an exciting time for this new generation of vaccines and our platform’s continued impact on human health. Read more from our CEO Stéphane Bancel about this approval, and what’s next: modernatx.com/en-US/media-center/all-media/blogs/introducing-worlds-first-rsv-

Getting the RSV (Respiratory syncytial virus) vaccination during pregnancy may reduce your baby’s chance of being hospitalised with RSV by up to 80%. The RSV vaccine is safe during pregnancy and can protect your infant from becoming seriously ill from RSV. For more information visit www.nhsinform.scot/rsv-baby #VaccinesInPregnancy | NHS Dumfries & Galloway

5.3K views | Ayesha had the new Respiratory Syncytial Virus (RSV) vaccine to protect her unborn baby. Her son had RSV when he was 4 weeks old so she knows the effects it can have on babies. This vaccine has the potential to prevent more than 1000 babies being admitted to hospital each year. If you're 28 weeks plus pregnant, speak to your midwife and get your RSV vaccine today! | Aneurin Bevan University Health Board | Facebook